Ginkgo Biloba: Memory, Focus and Dementia
Two large prevention trials, with 3,069 and 2,854 older adults, found that ginkgo did not prevent dementia or Alzheimer disease. Trials in people who already have dementia tell a different and less certain story.

Build your own printable peptide tracker
A personalized injection log, weekly dosing schedule and dated calendar: your compounds filled in, ready to print. Free to build and preview; $5/month to unlock printing.
How Is Ginkgo Thought to Work?
The standardized leaf extract EGb 761 contains two main groups of active compounds, flavonoid glycosides (24%) and terpene lactones (6%), with less than 5 ppm of ginkgolic acid, the allergenic component. Proposed actions include antioxidant, antiplatelet and microcirculatory effects (Ginkgo chemistry and safety review, PMID 18211362).
In 9 healthy men with a mean age of 61, 4 weeks of 60 mg ginkgo extract twice daily was followed by a small but significant rise in global cerebral blood flow on MRI perfusion scans, about 13% in gray matter and 15% in white matter. The pilot had no placebo group (ginkgo MR perfusion pilot, PMID 21061003).
Across 18 randomized trials with 1,985 adults, standardized ginkgo extract lowered blood viscosity but had no significant effect on ADP-induced platelet aggregation, fibrinogen, aPTT or prothrombin time (ginkgo bleeding meta-analysis, PMID 21923430).
In an open, non-randomized pilot of 16 depressed inpatients on trimipramine, the 8 who added 240 mg a day of ginkgo extract for 4 weeks had higher sleep efficiency and fewer awakenings on sleep recordings. Stopping ginkgo reversed most of these effects (adjunct ginkgo polysomnography pilot, PMID 11302564).
What the Data Shows
Daily Dosing Schedule
Key Takeaways
- Ginkgo did not prevent dementia in the GEM trial. Among 3,069 adults aged 75 or older followed for a median of 6.1 years, 120 mg twice a day gave a hazard ratio of 1.12 for all-cause dementia versus placebo (PMID 19017911), and it did not slow cognitive decline in any domain tested (PMID 20040554).
- GuidAge, a 5-year French trial of 2,854 adults aged 70 or older with memory complaints, found 61 Alzheimer cases on EGb 761 and 73 on placebo, a difference that was not significant (PMID 22959217).
- In healthy people, a meta-analysis found effect sizes close to zero for memory, executive function and attention (PMID 23001963), and a 6-week trial in 230 adults over 60 found no difference from placebo on any outcome (PMID 12186600).
- In diagnosed dementia, a meta-analysis of 7 trials found EGb 761 improved cognition, daily activities and global ratings more than placebo over 22 to 26 weeks (PMID 25506211). The 2026 Cochrane review rated the dementia evidence low certainty and found little to no effect in mild cognitive impairment (PMID 41641880).
- In dementia with behavioral and psychological symptoms, 240 mg a day of EGb 761 for 22 to 24 weeks improved those symptoms, except psychotic-like features, across 4 trials with 1,628 patients (PMID 28931444).
- In 107 patients with generalized anxiety disorder or adjustment disorder with anxious mood, Hamilton Anxiety scores fell 14.3 points on 480 mg, 12.1 on 240 mg and 7.8 on placebo over 4 weeks (PMID 16808927).
- In clotting studies, ginkgo did not change warfarin levels or INR in 12 healthy men (PMID 15801937), and adding 240 mg EGb 761 to 500 mg aspirin did not lengthen bleeding time beyond aspirin alone in 50 healthy men (PMID 16752942).
- Why the dementia results vary so much. The Cochrane dementia estimates showed high heterogeneity (I² of 88% to 96%) (PMID 41641880), and one meta-analysis found no extra benefit in its Alzheimer disease subgroup over the whole group (PMID 25114079).
- Whether ginkgo causes serious bleeding. A review of 15 case reports, 8 of them intracranial bleeds, judged a causal link possible, though 13 reports had other bleeding risk factors (PMID 16050865). The trial with aspirin lasted 4 weeks and was small (PMID 17982321).
- What a given bottle contains. In one lab study, 8 of 18 commercial ginkgo supplements were adulterated, mostly with rutin or quercetin (PMID 23451372). Products on the US market ranged from under 500 ppm to about 90,000 ppm of ginkgolic acids (PMID 12005361).
- What the rodent cancer finding means for people. In 2-year gavage studies by the National Toxicology Program, hepatocellular carcinoma rose in every dosed group of male mice, at 200 to 2,000 mg per kg of body weight (PMID 23652021).
- Whether ginkgo helps tinnitus. A Cochrane review of 12 studies with 1,915 participants found the evidence very uncertain, with little to no effect on symptom severity in the pooled data (PMID 36383762).
- Whether ginkgo helps sleep. The only sleep data here come from an open pilot of 16 depressed inpatients, without randomization (PMID 11302564).
- What single doses do to focus. Single doses of 240 mg and 360 mg sped attention in 20 young adults (PMID 11026748), while a pooled analysis of 78 young adults found 120 mg improved quality of memory but slowed speed of attention (PMID 17902186).
Frequently Asked Questions
Does ginkgo biloba improve memory?
Not with regular use in healthy adults, going by the trials. A meta-analysis of randomized trials in healthy people found effect sizes close to zero for memory, executive function and attention (ginkgo in healthy individuals meta-analysis, PMID 23001963). In a 6-week trial of 230 adults over 60, the 115 who took 40 mg three times a day did no better than the 115 on placebo on memory tests or self-reported memory (ginkgo memory enhancement trial, PMID 12186600). Single doses are less clear: in 78 healthy young adults, one 120 mg dose improved quality of memory but slowed speed of attention (single-dose 120 mg ginkgo reanalysis, PMID 17902186).
Can ginkgo prevent dementia or Alzheimer disease?
The two large prevention trials say no. In GEM, 3,069 adults aged 75 or older took 120 mg twice a day or placebo for a median of 6.1 years, and dementia rates did not fall (hazard ratio 1.12; Ginkgo Evaluation of Memory trial, PMID 19017911). In GuidAge, 2,854 adults aged 70 or older with memory complaints took EGb 761 for 5 years without a significant drop in Alzheimer cases (GuidAge trial, PMID 22959217).
Does ginkgo help people who already have dementia?
Possibly, by a small amount. A meta-analysis of 7 trials found that EGb 761 at 120 mg or 240 mg a day improved cognition, daily activities and global ratings more than placebo over 22 to 26 weeks (EGb 761 dementia meta-analysis, PMID 25506211). The 2026 Cochrane review described small to moderate benefits at 6 months but rated the evidence low certainty (Cochrane ginkgo for cognitive impairment and dementia, PMID 41641880).
Is ginkgo safe with blood thinners?
The trials and the case reports disagree, so ask a clinician first. A meta-analysis of 18 trials found no significant effect on platelet aggregation or clotting times (ginkgo bleeding meta-analysis, PMID 21923430), and ginkgo did not change warfarin levels or INR in 12 healthy men (ginkgo and warfarin study, PMID 15801937). A review of 15 case reports, including 8 intracranial bleeds, still judged a causal link to bleeding possible (ginkgo bleeding case review, PMID 16050865).
Are ginkgo nuts safe to eat?
Not in large amounts. A 48-year-old man had repeated generalized seizures after overeating ginkgo nuts, with raised blood 4-O-methylpyridoxine and low pyridoxal phosphate, and recovered after pyridoxal phosphate treatment (ginkgo nut intoxication case, PMID 32047675). The trials on this page used leaf extracts, not nuts.
Recommended Products
Support supplements and gear relevant to this protocol.
Affiliate links support HighPeptides at no extra cost.
Related HighPeptides Research
Peer-Reviewed References
67-page guide: protocols, dosing, sourcing. Everything in one place.
Get the guide: $19 (normally $29) → The Peptide Buyer’s Playbook ($19) All ebooks & guides →Educational purposes only. Not medical advice.
Ginkgo is sold in the US as a dietary supplement, not an FDA-approved drug. Talk to a clinician before using it if you take blood thinners, aspirin or other prescription medicines or have a bleeding disorder, or are pregnant.
Get the Free 2026 Peptide Protocol Stack
Twelve compounds across four pillars: metabolic, tissue repair, longevity, cognitive. Citations included, formatted to print. Sent straight to your inbox.